
Scaling up GLP-1 Production to Meet Global Demand: Boccard’s Contribution to a High-Growth Therapeutic Segment
As demand for GLP‑1 therapies grows in obesity and Type 2 diabetes care, manufacturers must rapidly scale production while meeting strict GMP requirements. This case study shows how Boccard delivered a robust and scalable GLP‑1 production line.









